Skip to content
TBC
lls
  • Home
  • All Episodes
    • CAR T-cell Therapy
    • Leukemia
    • Lymphoma
    • Myelodysplastic Syndromes
    • Myeloma & Amyloidosis
    • Pediatric and AYA
    • General Treatment & Support
  • Subscribe by Email
  • About
  • FAQs
  • Visit LLS.org

CAR T-cell Therapy: A Deeper Dive into Adverse Effects and Financial Toxicities

Sergio Giralt, MD, Memorial Sloan Kettering Cancer Center and Gunjan Shah, MD, Memorial Sloan Kettering Cancer Center

CAR T-cell Therapy: A 60,000 Foot View

Dennis Cooper, MD, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ

Unique Challenges for Young Adult Cancer Survivors: What You Should Know

Brad Zebrack, PhD, MSW, The University of Michigan School of Social Work, Ann Arbor, MI

Hearing the Patient’s Voice: A Discussion on Myelodysplastic Syndrome with a Survivor, a Caregiver, and a Physician

Richard, MDS survivor since 2016, Nancy, Caregiver, and Vu Duong, MD, University of Maryland School of Medicine, Baltimore, MD

A Conversation on AL Amyloidosis with Dr. Raymond Comenzo, MD

Raymond Comenzo, MD, Tufts Medical Center, Boston, MA

Part II of Understanding Multiple Myeloma

Paul Richardson, MD, Dana-Farber Cancer Institute, Boston, MA

Post navigation

« Previous 1 … 8 9 10 11 12 13 14 Next »

Categories

  • All Episodes (102)
  • CAR T-cell Therapy (11)
  • Clinical Trials (4)
  • COVID-19 (7)
  • General Treatment & Support (34)
  • Genomics (3)
  • Health Equity (8)
  • Leukemia (23)
  • Lymphoma (15)
  • Minimal Residual Disease (MRD) (4)
  • Myelodysplastic Syndromes (6)
  • Myeloma & Amyloidosis (14)
  • Myeloproliferative Neoplasms (4)
  • Pediatric and AYA (13)
  • Rare Blood Cancers (4)
  • Transplantation (4)
  • Waldenström macroglobulinemia (2)

Find us on your favorite podcatchers

Apple PodcastsSpotifyAmazon MusicAndroidiHeartRadioJioSaavnPodchaserPodcast Indexby EmailRSSMore Subscribe Options
2024 Treating Blood Cancers Podcast Series – The Leukemia & Lymphoma Society